Helsinki, Finland

Timo Arto Sorsa

USPTO Granted Patents = 12 

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 143(Granted Patents)


Company Filing History:


Years Active: 1998-2023

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Timo Arto Sorsa: Innovating in Cartilage Health

Introduction

Timo Arto Sorsa, an esteemed inventor based in Helsinki, Finland, has contributed significantly to the field of medical innovations. With a total of 12 patents to his name, Sorsa's work focuses primarily on advancements related to cartilage health and disease detection.

Latest Patents

Among Sorsa's latest patents are groundbreaking inventions that address cartilage degradation and its associated conditions. One notable patent is for Hica, or 2-Hydroxy-isocaproic acid, aimed at the prophylaxis and treatment of diseases involving cartilage homeostasis and integrity. This innovative compound holds promise in preventing and treating conditions that lead to cartilage degradation. Another significant patent pertains to an MMP-8 activation product, which includes methods for detecting this product in biological samples, contributing to the diagnosis of diseases linked to abnormal MMP-8 levels.

Career Highlights

Timo Arto Sorsa has employed his expertise at various notable organizations, including Oy Medix Biochemica Ab and the Research Foundation of State University of New York. His career reflects a commitment to enhancing health technologies through innovative research and development.

Collaborations

Throughout his career, Sorsa has collaborated with esteemed professionals, notably Lorne M. Golub and Olli P. Teronen. These collaborations have likely enriched his inventions, bringing diverse expertise and perspectives to his research endeavors.

Conclusion

In summary, Timo Arto Sorsa stands out as a significant figure in the field of medical invention, particularly regarding cartilage health. His innovative patents and collaborative efforts highlight his dedication to advancing healthcare solutions that can profoundly benefit individuals facing cartilage-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…